SEC Form D · Amendment · filed July 13, 2023
Venatorx Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Timothy J. Haines · Malvern, PADirectorSergei J. Petukhov · Malvern, PADirectorMartin J. Heidecker · Malvern, PADirectorChristopher J. Burns · Malvern, PAExec · DirectorAnthony J. Meehan · Malvern, PAExecDaniel C. Pevear · Malvern, PAExecIsaac H. Kalish · Great Neck, NYExecBenjamin H. Bolanos · Great Neck, NYExecHuber Klaus · denvor, CODirectorSteven H. Rosenzweig · Great Neck, NYDirectorAndrew Firman · Dallas, TXDirectorWyatt Cavalier · Wilmington, DEExec · DirectorTomas C. Heyman · Malvern, PADirectorMatt M. Whelan · Long Island City, NYDirectorDavid M. Langer · Long Island City, NYExec · DirectorClay Brock · Wilmette, ILDirectorOrin Wolf · NEW YORK, NYExecArabella FCRE Management, LLC · Alpharetta, GAExecJeff J. Seavey · Houston, TXDirectorTomas C. Heyman · Malvern, PADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗